INTRODUCTION: Atopic dermatitis (AD) is a chronic, inflammatory skin disease known for its hallmark symptom of pruritus. We developed Worst Pruritus Numeric Rating Scale (NRS)—a single-item, …

Razavi P, Ahmed M, Roush A, Parikh R, Hitchens A, Shen S, Safonov A, Jhaveri K, Robson M, Peacock N, Ma Y, Santarsiero E, Ganapathy V, Shah R, Amaefule A, Lteif A, Blakely J. Real-world (RW) risk …

BACKGROUND: Intravenous (IV) therapies often impose significant burdens and costs on payers, providers, patients, and caregivers. A fixed-dose subcutaneous (SC) formulation may enhance …

BACKGROUND: Tildrakizumab, a high-affinity, humanized, IgG1 κ, anti-interleukin–23 monoclonal antibody, was recently approved in the United States (U.S.) to treat moderate-to-severe plaque …

AIM: To evaluate patients' expectations regarding the perceived utility of whole-genome sequencing (WGS).

Adelakun A, Dolph M, Matthews E, Oglebsy A, Campbell K, Davis A, Xu J, Hardy I, Danchenko N, Anderson SJ. Cost-effectiveness and public-health impact of cabotegravir long-acting injectable for …

AIM: Determine whether using CYP2C19 genotype to optimize antiplatelet therapy selection is cost effective over the initial 30 days and 1-year following percutaneous coronary intervention.

AIMS: To build a flexible and comprehensive long-term type 1 diabetes mellitus model incorporating the most up-to-date methodologies to allow a number of cost-effectiveness evaluations.

Ambulatory assessment methods (e.g., ecological momentary assessment [EMA], daily diary) are used to study the impact of daily stress on physical and mental health and behavior. However, there is …

BACKGROUND: Medullary thyroid cancer (MTC) accounts for approximately 1.6% of new cases of thyroid cancer. The objective of this study was to describe patient characteristics, biomarker testing, …